Earnings
IMUX
14.31
-4.41%
-0.66
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
127.45M
--
--
--
--
--
295.00K
--
--
--
3.42M
2.58M
133.75M
1.10M
--
--
--
32.97M
--
--
42.00K
34.12M
167.86M
--
3.70M
0.00
--
--
--
--
--
4.32M
--
--
--
379.00K
8.40M
0.00
--
--
--
679.00K
679.00K
9.08M
2000.00
266.82M
-103.93M
--
--
--
158.78M
158.78M
167.86M
FY 2019-12-31
29.37M
--
--
--
--
--
0.00
--
--
--
2.86M
--
32.23M
713.00K
--
--
--
32.97M
--
--
42.00K
33.73M
65.95M
--
2.42M
0.00
--
--
--
--
--
3.30M
--
--
--
1.35M
7.07M
0.00
--
--
--
520.00K
520.00K
7.59M
1000.00
119.65M
-59.91M
--
--
--
58.36M
58.36M
65.95M
FY 2018-12-31
13.32M
--
--
--
--
--
0.00
--
--
--
908.00K
--
14.23M
709.00K
--
--
--
--
--
--
37.00K
746.00K
14.98M
--
268.00K
0.00
--
--
--
--
--
2.22M
--
--
--
21.00K
2.51M
0.00
--
--
--
41.00K
41.00K
2.55M
4000.00
349.77M
-337.43M
--
--
--
12.43M
12.43M
14.98M
FY 2017-12-31
56.90M
--
--
--
--
--
0.00
--
--
--
1.22M
--
58.12M
2.15M
--
--
--
--
--
--
108.00K
2.26M
60.38M
--
1.05M
0.00
--
--
--
--
--
9.14M
--
--
--
91.00K
10.28M
0.00
--
--
--
59.00K
59.00K
10.34M
4000.00
345.92M
-295.95M
--
--
--
50.04M
50.04M
60.38M
FY 2016-12-31
59.99M
--
--
--
--
--
0.00
--
--
--
1.47M
0.00
61.46M
2.50M
--
--
--
--
--
--
58.00K
2.56M
64.03M
--
780.00K
0.00
--
--
--
--
--
4.66M
--
--
--
44.00K
5.48M
0.00
--
--
--
100.00K
100.00K
5.58M
3000.00
302.19M
-243.82M
--
--
--
58.45M
58.45M
64.03M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out IMUX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Immunic Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.